Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01272635 · ClinicalTrials.gov registry record · Phase 3

Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.

A Phase 3 study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
Phase 3
Development phase
607
Enrollment target

NCT01272635 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 607 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01272635, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
Phase 3
Development phase
607 participants
Enrollment target

Study Summary

This protocol is comprised of two separate, but linked, clinical trials for treating preschool-aged children with recurrent severe episodes of wheezing. The first study (APRIL) will try to prevent wheezing illness from developing using azithromycin. If a wheezing illness does occur, the second trial (OCELOT) will try to decrease the severity of symptoms using oral corticosteroids.

Interventions

  • DRUG Azithromycin
  • DRUG Prednisolone
  • OTHER Placebo Azithromycin
  • DRUG Placebo Prednisolone

Trial Details

FieldValue
Enrollment Target 607 participants
Start Date 2011-03
Est. Completion 2015-01
Phase Phase 3

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT01272635

The ClinicalTrials.gov registry entry for NCT01272635 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 607 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Azithromycin is the first listed.

NCT01272635 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01272635 about?

NCT01272635 is a clinical study titled "Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.". This protocol is comprised of two separate, but linked, clinical trials for treating preschool-aged children with recurrent severe episodes of wheezing. The first study (APRIL) will try to prevent wheezing illness from developing using azithromycin. If a wheezing illness does occur, the second trial...

What is the current status of trial NCT01272635?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 607 participants. The study started on 2011-03. Estimated completion is 2015-01.

What interventions are being tested in trial NCT01272635?

The interventions under investigation include: Azithromycin (DRUG), Prednisolone (DRUG), Placebo Azithromycin (OTHER), Placebo Prednisolone (DRUG).

Who is sponsoring clinical trial NCT01272635?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.